These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 21646750

  • 1. Amino acid substitution at position 95 in rabies virus matrix protein affects viral pathogenicity.
    Ito N, Mita T, Shimizu K, Ito Y, Masatani T, Nakagawa K, Yamaoka S, Abe M, Okadera K, Minamoto N, Sugiyama M.
    J Vet Med Sci; 2011 Oct; 73(10):1363-6. PubMed ID: 21646750
    [Abstract] [Full Text] [Related]

  • 2. Amino acid at position 95 of the matrix protein is a cytopathic determinant of rabies virus.
    Mita T, Shimizu K, Ito N, Yamada K, Ito Y, Sugiyama M, Minamoto N.
    Virus Res; 2008 Oct; 137(1):33-9. PubMed ID: 18602710
    [Abstract] [Full Text] [Related]

  • 3. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice.
    Shimizu K, Ito N, Mita T, Yamada K, Hosokawa-Muto J, Sugiyama M, Minamoto N.
    Virus Res; 2007 Feb; 123(2):154-60. PubMed ID: 17010466
    [Abstract] [Full Text] [Related]

  • 4. Generation of a live rabies vaccine strain attenuated by multiple mutations and evaluation of its safety and efficacy.
    Nakagawa K, Ito N, Masatani T, Abe M, Yamaoka S, Ito Y, Okadera K, Sugiyama M.
    Vaccine; 2012 May 21; 30(24):3610-7. PubMed ID: 22464967
    [Abstract] [Full Text] [Related]

  • 5. Analyses of cell death mechanisms related to amino acid substitution at position 95 in the rabies virus matrix protein.
    Kojima I, Izumi F, Ozawa M, Fujimoto Y, Okajima M, Ito N, Sugiyama M, Masatani T.
    J Gen Virol; 2021 Apr 21; 102(4):. PubMed ID: 33891533
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A highly attenuated rabies virus HEP-Flury strain reverts to virulent by single amino acid substitution to arginine at position 333 in glycoprotein.
    Takayama-Ito M, Inoue K, Shoji Y, Inoue S, Iijima T, Sakai T, Kurane I, Morimoto K.
    Virus Res; 2006 Aug 21; 119(2):208-15. PubMed ID: 16473429
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Single Amino Acid Substitution in the Matrix Protein of Rabies Virus Is Associated with Neurovirulence in Mice.
    Harada M, Matsuu A, Kaku Y, Okutani A, Inoue Y, Posadas-Herrera G, Inoue S, Maeda K.
    Viruses; 2024 Apr 28; 16(5):. PubMed ID: 38793581
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Defect of rabies virus phosphoprotein in its interferon-antagonist activity negatively affects viral replication in muscle cells.
    Yamaoka S, Okada K, Ito N, Okadera K, Mitake H, Nakagawa K, Sugiyama M.
    J Vet Med Sci; 2017 Aug 10; 79(8):1394-1397. PubMed ID: 28674326
    [Abstract] [Full Text] [Related]

  • 12. Efficient N-glycosylation at position 37, but not at position 146, in the street rabies virus glycoprotein reduces pathogenicity.
    Yamada K, Noguchi K, Nishizono A.
    Virus Res; 2014 Jan 22; 179():169-76. PubMed ID: 24177272
    [Abstract] [Full Text] [Related]

  • 13. The Amino Acid at Position 95 in the Matrix Protein of Rabies Virus Is Involved in Antiviral Stress Granule Formation in Infected Cells.
    Kojima I, Onomoto K, Zuo W, Ozawa M, Okuya K, Naitou K, Izumi F, Okajima M, Fujiwara T, Ito N, Yoneyama M, Yamada K, Nishizono A, Sugiyama M, Fujita T, Masatani T.
    J Virol; 2022 Sep 28; 96(18):e0081022. PubMed ID: 36069552
    [Abstract] [Full Text] [Related]

  • 14. Rabies virus nucleoprotein functions to evade activation of the RIG-I-mediated antiviral response.
    Masatani T, Ito N, Shimizu K, Ito Y, Nakagawa K, Sawaki Y, Koyama H, Sugiyama M.
    J Virol; 2010 Apr 28; 84(8):4002-12. PubMed ID: 20130065
    [Abstract] [Full Text] [Related]

  • 15. Serial passage of a street rabies virus in mouse neuroblastoma cells resulted in attenuation: potential role of the additional N-glycosylation of a viral glycoprotein in the reduced pathogenicity of street rabies virus.
    Yamada K, Park CH, Noguchi K, Kojima D, Kubo T, Komiya N, Matsumoto T, Mitui MT, Ahmed K, Morimoto K, Inoue S, Nishizono A.
    Virus Res; 2012 Apr 28; 165(1):34-45. PubMed ID: 22248643
    [Abstract] [Full Text] [Related]

  • 16. A unique substitution at position 333 on the glycoprotein of rabies virus street strains isolated from non-hematophagous bats in Brazil.
    Sato G, Kobayashi Y, Motizuki N, Hirano S, Itou T, Cunha EM, Ito FH, Sakai T.
    Virus Genes; 2009 Feb 28; 38(1):74-9. PubMed ID: 18941881
    [Abstract] [Full Text] [Related]

  • 17. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity.
    Ito N, Moseley GW, Blondel D, Shimizu K, Rowe CL, Ito Y, Masatani T, Nakagawa K, Jans DA, Sugiyama M.
    J Virol; 2010 Jul 28; 84(13):6699-710. PubMed ID: 20427527
    [Abstract] [Full Text] [Related]

  • 18. Region at amino acids 164 to 303 of the rabies virus glycoprotein plays an important role in pathogenicity for adult mice.
    Takayama-Ito M, Ito N, Yamada K, Minamoto N, Sugiyama M.
    J Neurovirol; 2004 Apr 28; 10(2):131-5. PubMed ID: 15204932
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene.
    Shimizu K, Ito N, Sugiyama M, Minamoto N.
    Microbiol Immunol; 2006 Apr 28; 50(12):975-8. PubMed ID: 17179666
    [Abstract] [Full Text] [Related]

  • 20. Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein.
    Nakagawa K, Nakagawa K, Omatsu T, Katayama Y, Oba M, Mitake H, Okada K, Yamaoka S, Takashima Y, Masatani T, Okadera K, Ito N, Mizutani T, Sugiyama M.
    Vaccine; 2017 Oct 09; 35(42):5622-5628. PubMed ID: 28882441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.